Dr. Yasmin Thanavala on targeted therapy for liver cancer
2 Visualizações
• 06/28/23
0
0
Embutir
administrator
Assinantes
Yasmin Thanavala, PhD, of the Department of Immunology and the Tumor Immunology and Immunotherapy program at Roswell Park Cancer Institute, discusses new research that may help identify those patients with advanced liver cancer who will benefit most from the targeted therapy sorafenib. Read more: http://goo.gl/W0jPX2
Mostre mais
Comentários do Facebook
SORT BY-
Melhores Comentários
-
Últimos Comentários